The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma

医学 腺鳞癌 肝细胞癌 外科肿瘤学 内科学 胃肠病学 原发性肿瘤 转移 肿瘤科 癌症 腺癌
作者
Yan Long,Feng Xie,Cheng Yang,Lihan Yu,Tao Zheng,Jun Fu,Jiamei Yang
出处
期刊:World Journal of Surgical Oncology [BioMed Central]
卷期号:13 (1) 被引量:17
标识
DOI:10.1186/s12957-015-0464-2
摘要

There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we did this retrospective study.We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern Hepatobiliary Surgery Hospital in China. Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in the same period were also reviewed to make a comparison. In order to find out the definite survival information of SCC and ASC patients, 30 previous studies containing 37 primary hepatic SCC (16) and ASC (21) patients were reviewed, and their information of survival was analyzed together with the included patients in our hospital.Serum tumor markers showed significant differences between primary hepatic SCC/ASC and HCC patients, especially for serum alpha fetal protein (AFP) level and carbohydrate antigen 19-9 (CA 19-9). On the pathologic performance, primary SCC/ASC tumor was rarely accompanied with tumor capsule. They presented peripheral hepatic lymph node metastasis more likely and showed low proportion of microvascular invasion. The median survival time of primary hepatic SCC/ASC patients after liver resection (LR) was 15 months. And the 1-, 3-, 5-year survival rates after LR were 60%, 24%, and 12%, respectively. Significant difference was not discovered when SCC and ASC patients were compared with HCC patients (P = 0.294). The median survival time after LR for primary SCC and ASC patients was respectively 23 months and 13 months.The comprehensive application of some clinical characteristics, histopathologic features, and imaging findings may be useful for us in making definite diagnoses for primary hepatic SCC and ASC patients preoperatively. And the treatment of liver resection was effective for those patients who met the selection criteria for liver resection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
海子啊完成签到,获得积分10
1秒前
科研通AI6.3应助橙汁采纳,获得10
4秒前
qiqiya77完成签到 ,获得积分10
4秒前
小小莫发布了新的文献求助10
7秒前
科研通AI6.2应助11采纳,获得10
11秒前
12秒前
猪脑过载完成签到 ,获得积分10
12秒前
PinkBro完成签到,获得积分10
14秒前
SciGPT应助安静的初翠采纳,获得30
15秒前
东风应助xueshufengbujue采纳,获得100
15秒前
梁晓雯完成签到 ,获得积分10
16秒前
小手冰凉完成签到 ,获得积分10
16秒前
17秒前
12345完成签到,获得积分10
17秒前
科研通AI6.1应助油菜籽采纳,获得10
17秒前
17秒前
团子小姐发布了新的文献求助10
17秒前
汉堡包应助王音博采纳,获得10
18秒前
18秒前
称心曼安发布了新的文献求助10
21秒前
Owen应助怡然的枕头采纳,获得10
22秒前
chenshiyi185发布了新的文献求助10
22秒前
linlin发布了新的文献求助10
22秒前
22秒前
charliechen完成签到 ,获得积分10
23秒前
24秒前
陌上花开完成签到,获得积分0
25秒前
bijialcl完成签到,获得积分10
25秒前
26秒前
菠菜菜str发布了新的文献求助10
29秒前
一朵约尔发布了新的文献求助10
29秒前
29秒前
30秒前
okt111发布了新的文献求助10
32秒前
大模型应助悟空最可爱采纳,获得10
32秒前
34秒前
35秒前
香香完成签到,获得积分10
35秒前
明理寻菡发布了新的文献求助10
35秒前
高分求助中
液晶指向矢仿真分析数据集 8888
Invited Discussant 63O and 64O 1000
Ideology and Meaning-Making under the Putin Regime 750
Advanced Memory Technology 500
Petrology and Plate Tectonics 500
Writing Systems 500
A Handbook of User Experience Research & Design in Libraries 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6864868
求助须知:如何正确求助?哪些是违规求助? 8567533
关于积分的说明 18217310
捐赠科研通 6233874
什么是DOI,文献DOI怎么找? 3048974
关于科研通互助平台的介绍 2050744
邀请新用户注册赠送积分活动 2026727